Collectively, our study illustrated that GP73-mediated secretion of PKM2 and GP73 promotes HCC progression by remodeling the TME, and GP73 and PKM2 can act as new therapeutic targets for HCC. This evidence concerns the gene PKM and hepatocellular carcinoma.